Page 17 of 19 · 436 questions tagged vendor-vetting.
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I want a method I can write down and repeat, not a rule of thumb. I would…
I have the report as a PDF with the chromatogram on page two, so I can quote specifics. I want a method I can write down and repeat, not a rule of thumb. I would…
The method section is present, which is unusual enough that I want to make use of it. I am trying to do this correctly the first time rather than learn it by getting…
What I am working with: ERP · cagrilintide. This is not behaving the way I expected and I want to understand the discrepancy before I act on it. I have photographed…
The method section is present, which is unusual enough that I want to make use of it. I would like help reading this properly rather than being told what conclusion…
I have both a purity figure and a content figure, which is why the discrepancy is visible. I have the document in front of me and I can read the numbers. What I…
I have kept every message, invoice and document, which I gather is the useful habit. I would rather be corrected now than propagate something wrong. I am specifically…
Concretely: survodutide · method section. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single…
Conditions: 98.8% · tirzepatide · WXT. The failure mode I am trying to avoid is making this decision emotionally. I have twelve months in view and I would like the…
The lot number on the vial matches the certificate, which at least rules out the easy problem. I would like to know the limits of what can be inferred from this. What…
What I am working with: purity figure · JEEP. I would like help reading this properly rather than being told what conclusion to reach. I have the full report…
The pharmacy is accredited and I have verified that on the accreditor register. I have read the primary source rather than the summary, which has left me with more…
I am comparing three suppliers on documentation rather than on price. I am trying to do this correctly the first time rather than learn it by getting it wrong. I have…
Conditions: chromatogram · MKM. I would like to know the limits of what can be inferred from this. What I am trying to avoid is over-reading a single result, which I…
The case in front of me: 99.1% · liraglutide · FGP. I want to decide this in advance so that I am not deciding it under pressure later. Assume I will follow the plan…
Stated plainly: BCH · a GLP-1 receptor agonist. I noticed this today and I have not touched anything since, in case the state is diagnostic. I have not discarded…
I am comparing a supplier certificate against an independent result on the same lot. Both of these get recommended confidently by different people, which suggests…
Numbers first: SGN · WuXi TIDES. I want to know what the trade-off actually is rather than which option is fashionable. I would rather have a defensible reason than a…
This is my second independent submission on material from the same supplier. I would like to know whether this claim survives contact with evidence. If the answer is…
Numbers first: JEEP · Shanghai ERP Biotechnology. I have used one of these for a while and I am considering switching, which requires a reason. What I care about is…
I have kept every message, invoice and document, which I gather is the useful habit. I would like to understand the steps well enough to explain them to someone else.…
The particulars: PeptideMeter · Hunan Aslsen Technology. I have the document in front of me and I can read the numbers. What I cannot do is interpret them. I am…
This is a first order from this supplier, so I have no track record to reason from. I have read the primary source rather than the summary, which has left me with…
The case in front of me: HJ · Wuhan Wansheng Biotechnology. I would like the axes of comparison first and the recommendation second. I have tried the first option and…